News

26May, 2021

CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification

Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples. BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine [...]

22May, 2020

Free Webinar: Drawing NGS Plasma at Time of Lung Biopsy

  CIRCULOGENE Free Webinar Drawing NGS Plasma at Time of Lung Biopsy, To Do or Not To Do Jun 3, 2020 7:00PM Eastern Time Please join us for this free educational webinar where our panel [...]

21Apr, 2020

Cell-Free DNA Concentration Associated with Injury Severity and Survival in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology

 Cell-Free DNA Concentration Associated with Injury Severity and Survival  in ICU Animal Study using CIRCULOGENE’s Proprietary Liquid Biopsy Technology   cfDNA levels correlate significantly with biomarkers of multiorgan damage in first abstract stemming from DOD research grant to [...]